Literature DB >> 22359163

Dexamethasone regulation of terminal differentiation in 3T3-F442A preadipocyte cell line.

N Moustaïd1, B Hainque, A Quignard-Boulangé.   

Abstract

The 3T3-F442A preadipocyte cell line was previously shown to possess specific glucocorticoid receptors whose number increased in the time course of differentiation. We have examined the effects of a three day dexamethasone treatment, added at confluence, on cells differentiated in the presence or absence of insulin. Triglyceride accumulation, polyamine content as well as glycerophosphate dehydrogenase and fatty acid synthetase activities were measured during the adipose conversion. We have also determined 2-deoxyglucose uptake in non-differentiated and differentiated cells. Dexamethasone was shown to decrease the adipose conversion by 3T3-F442A cells in the presence or absence of insulin. Intracellular spermidine content in differentiating cells was sensitive to dexamethasone and insulin in the same way as an enzymatic marker of terminal differentiation, glycerophosphate dehydrogenase. Dexamethasone decreases the 2 deoxyglucose uptake in non-differentiated and differentiated cells while insulin increases this uptake only in differentiated cells. This work shows that glucocorticoids inhibit adipocyte metabolism at distinct levels and suggests that these hormones might play an important role in the regulation of adipose tissue mass.

Entities:  

Year:  1988        PMID: 22359163     DOI: 10.1007/BF00365073

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  40 in total

1.  Induction of lipogenesis during differentiation in a "preadipocyte" cell line.

Authors:  J C Mackall; A K Student; S E Polakis; M D Lane
Journal:  J Biol Chem       Date:  1976-10-25       Impact factor: 5.157

2.  An established preadipose cell line and its differentiation in culture. II. Factors affecting the adipose conversion.

Authors:  H Green; O Kehinde
Journal:  Cell       Date:  1975-05       Impact factor: 41.582

3.  Regulation of insulin receptors and insulin responsiveness in 3T3-L1 fatty fibroblasts.

Authors:  F A Karlsson; C Grunfeld; C R Kahn; J Roth
Journal:  Endocrinology       Date:  1979-05       Impact factor: 4.736

4.  Effect of insulin and glucocorticoids on glucose transporters in rat adipocytes.

Authors:  C Carter-Su; K Okamoto
Journal:  Am J Physiol       Date:  1987-04

5.  Corticosteroids as long-term regulators of the insulin effectiveness in mouse 3T3 adipocytes.

Authors:  J P van Putten; T Wieringa; H M Krans
Journal:  Diabetologia       Date:  1985-07       Impact factor: 10.122

6.  Participation of one isozyme of cytosolic glycerophosphate dehydrogenase in the adipose conversion of 3T3 cells.

Authors:  L S Wise; H Green
Journal:  J Biol Chem       Date:  1979-01-25       Impact factor: 5.157

7.  Nucleotide sequence and hormonal regulation of mouse glycerophosphate dehydrogenase mRNA during adipocyte and muscle cell differentiation.

Authors:  D E Dobson; D L Groves; B M Spiegelman
Journal:  J Biol Chem       Date:  1987-02-05       Impact factor: 5.157

8.  Hemin enhances the differentiation of mouse 3T3 cells to adipocytes.

Authors:  J J Chen; I M London
Journal:  Cell       Date:  1981-10       Impact factor: 41.582

9.  Conversion of 3T3 fibroblasts into adipose cells: triggering of differentiation by prostaglandin F2alpha and 1-methyl-3-isobutyl xanthine.

Authors:  T R Russell; R Ho
Journal:  Proc Natl Acad Sci U S A       Date:  1976-12       Impact factor: 11.205

10.  Glycerol-3-phosphate dehydrogenase mRNA content in cultured 3T3-L1 adipocytes: regulation by dibutyryl cyclic AMP.

Authors:  B Bhandari; R E Miller
Journal:  Biochem Biophys Res Commun       Date:  1985-09-30       Impact factor: 3.575

View more
  1 in total

Review 1.  Approaches to Measuring the Activity of Major Lipolytic and Lipogenic Enzymes In Vitro and Ex Vivo.

Authors:  Marek Wilhelm; Lenka Rossmeislová; Michaela Šiklová
Journal:  Int J Mol Sci       Date:  2022-09-21       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.